Aspergillus fumigatus is an opportunistic airborne pathogen and one of the most common 40 causative agents of human fungal infections. A restricted number of virulence factors have 41 been described but none of them lead to a differentiation of the virulence level among 42 different strains. In this study, we analyzed the whole-genome sequence of a set of A. 
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Introduction 72
Aspergillus fumigatus (A. fumigatus) is an opportunistic fungal pathogen that poses one of the 73 major threats to immunocompromised individuals in the clinic. High risk patients include 74 neutropenic patients, hematopoietic stem cell transplant recipients, patients receiving a 75 prolonged steroid treatment and critically-ill patient in the intensive care unit (ICU) with 76 chronic obstructive pulmonary disease (COPD), liver cirrhosis, viral infections or microbial 77 sepsis (1-3). In the context of an impaired immune function, inhaled airborne spores of A. 78 fumigatus will not be effectively eliminated and will remain in human airways to cause a 79 range of infections that include allergic bronchopulmonary aspergillosis (ABPA), aspergilloma 80 (chronic aspergillosis) and invasive aspergillosis (IA) (1, 4) . IA is the most serious infection, 81
with a global prevalence of 250,000 cases per year with mortality rates up to 90-95% (5,6) . 82
In addition to the increasing burden of patients with impaired immunity (1), another major 83 challenge is the treatment of these fungal infections due to the antifungal resistance to 84 triazoles, the most indicated drugs against Aspergillus species infections. Resistance is 85 characterized by the presence of a point mutation (L98H) in the azole target Cyp51A and a 34-86 base pair (bp) tandem repeat (TR34) in its promoter region (7) and the most common cause 87 of resistance acquisition is the widespread azole-based fungicide use against fungal plant 88 pathogens in the agricultural practice (7) (8) (9) . 89
In order to overcome the therapeutic challenges and threats posed by A. fumigatus infections, 90
there is a need to further understand the mechanisms of adaptability and infection of the 91 fungus to develop better and early diagnostic tools and uncover novel therapeutic strategies. 92
The virulence of A. fumigatus is multifactorial, a trait that has been developed by the fungus as 93 a need to survive the encountered selective pressures in decaying vegetation (10). Whole-94 genome and transcriptome analysis have allowed the discovery and study of new components 95 of A. fumigatus biology and pathogenesis, providing a better understanding of the genetic 96 content of Aspergillus spp. Genomic analyses identified that A. fumigatus contains 8.5% of 97 lineage-specific (LS) genes with accessory functions for carbohydrate and amino acid 98 metabolism, transport, detoxification, or secondary metabolite biosynthesis, suggesting this 99 microorganism has particular genetic determinants that can facilitate an in vivo infection (11) . 100 Nevertheless, the study of A. fumigatus virulence has been hampered by the lack of a standard 101 wild-type (WT) strain, next to a broad isolate-dependent variability in virulence as shown in 102 murine infection models of IA (12) . A. fumigatus isolates can be divided in three different 103 categories depending on the source of isolation: 1) environmental, obtained from decaying 104 virulence genes appears to be flanked by these repetitive regions on both sides, whereas some 171 groups are only flanked on one side as depicted in chromosomes 6 and 8. 172
Genomic variability among the fungal genomes. Variant calling using as reference the A. 173 fumigatus Af293 genome, identified a total number of 68,352; 48,590; 56,362 and 56,422 174 variants in the genome of B5233, P1MS, P1MR and P2CS isolates, respectively (Table 3) . High 175 and moderate impact variants were retrieved, and their predicted effect is displayed in Table  176 S3. Among variations with a predicted moderate-and high-impact, a high number of missense 177 variants, ranging from 9,804 to 12,067, was identified. Single nucleotide polymorphism (SNP) 178 analysis in VRGs with respect to reference Af293 revealed the presence of a range of 1,015 -179 1,122 SNPs in all the analyzed isolates ( Table 3) . Examples of some variants present in the 180 VRGs are listed in Table 4 and a more detailed description is given in supplementary Table S4 . 181
No clear pattern of variant distribution was found regarding the source the isolates. Rather, 182
we observed some cases where all isolates had common variants as demonstrated in genes 183 thtA, sidC and msdS. Genes associated to resistance to the immune response rodB, cat1 and 184 afpmt2 had only one or no variants suggesting they are highly conserved genes. 
environments. 209
The only gene amongst the 244 VRGs included in our in-house database, not found in the 210 isolates B5233 and 08-12-12-13 was Afu5g12720. Interestingly, this gene was reported to be 211 absent in 21 out of 66 A. fumigatus samples in a population genomics study that investigated 212 the genomic variation of secondary metabolites in this species (23). This gene is a member of 213 the BGC 17, and its absence could have a functional impact on the synthesis of the final 214 product of this cluster, a NRPS, which is thought to have a structural function (19). 215
Afu5g12720 codes for an ABC transporter located in the BGC17 with another 9 genes (18) and 216 was curiously absent in B5233, a strain that has been described as highly virulent. It would be 217 interesting to further study the link between the lack of this gene and a possible increase in 218 virulence, since disruption of another gene member included in this BGC17, pes3, resulted in a 219 hypervirulent strain (19) . 220
Additional changes in the genome structure of our isolates were found in our comparative 221 genomic analysis. We identified deleted segments in relation to the reference that were 222 located at the beginning of chromosome 1 and at the end of chromosomes 5, 6 and 7. 223
Fedorova et al, identified these subtelomeric regions to be enriched for the presence of 224 pseudogenes, transposons and other repetitive elements, and corresponding to areas that 225 contain genes specific to the A. fumigatus species. (11) It was hypothesized that these genes 226 have most likely evolved from big duplication and diversification events and not horizontal 227 gene transfer. (11) It seems isolates B5233, P1MS and P1MR also do not have these genes. Our 228 hypothesis is that these segments, are insertion-prone regions that are contributing to the 229 diversification of the species. 230
Nucleotide variant analysis of our four isolates, identified a total number of variations ranging 231 from 48,590 to 68,352 compared to reference strain Af293. This range fits in the genetic 232 diversity for A. fumigatus reported previously and determined in 95 sequences ranging from 233 36 -72,000 SNPs (16). The large number of identified variants and differences in the genome 234 structure displays a broad genetic diversity in the studied isolates. This diversity is 235 hypothesized to directly influence the fungus virulence by allowing an adaptation to an in-236 host environment, the evasion of the host immune system and the acquisition of antifungal 237 resistance (17, 24, 25, 27) . The presence of SNPs in the VRGs of the clinical isolates, particularly 238 those to be predicted to have a high impact, could be of major influence for the virulence of 239 the isolates. However, in this study we could not link the presence of genetic changes in VRGs 240 to isolates with a common origin of isolation. In addition, some repetitive elements were 241 located on the sides of some groups of VRG as exemplified on chromosomes 6 and 8. It is 242 possible they could play a role in how some of these genes are expressed, since these elements 243 are recognized to shape the genomes of fungi (28). Follow-up studies using RNA sequencing 244 could help to elucidate how and under what circumstances these virulence genes are 245 expressed, as well as to determine the impact of genomic variations on expression levels. 246
Subsequent infection model studies could be used to correlate these genomic variations and 247 changes with specific pathogenic phenotypes. 248
The genome sequence of isolates P1MS and P1MR differed by 45,335 variants and they were 249 confirmed to have different genotypes, supporting the hypothesis that resistance did not 250 develop from the initial susceptible isolate. It is also unlikely that in a period of nine days the 251 susceptible isolate would have been able to mutate to acquire azole resistance since the 252 median time of development of azole resistance has been reported to be 4 months (29) . 253
Moreover, gain of the resistant phenotype within the host is observed in chronic infections 254 whereas acquisition of resistance during IA continues to be unreported (24). In a similar case 255 of post-influenza aspergillosis, four A. fumigatus isolates were obtained from a patient that 256 received an allogeneic stem cell transplant and developed IA after the influenza virus infection 257 which was initially treated with voriconazole (30). The patient passed away 4 months later. 258
The first three isolates were susceptible to azole treatment but the last one, demonstrated 259 triazole-resistance. It was confirmed that the resistant isolate was different from the first 260 isolates by STRAf microsatellite genotyping (30). It is likely that the resistant phenotype of the 261 resistant isolate in both our study and the post-influenza study (30), was of environmental 262 origin and that this isolate had coexisted with the susceptible isolates in a mixed population 263 that was not detected during the first sampling. Treatment with voriconazole most probably 264 eradicated the initial susceptible strain and through selective pressure, allowed the resistant 265
A. fumigatus strains to persist in the patient's airways. Because of this possibility, a change of 266 practice regarding A. fumigatus isolation has been applied at the diagnostics laboratory at the 267 UMCG where antifungal susceptibility testing is now applied to at least five colonies obtained 268 from a single respiratory sample. Influenza virus infection has been recently described as an 269 independent risk factor for invasive pulmonary aspergillosis and, therefore, extreme care for 270 patients admitted into the ICU with a severe influenza virus infection is advised (31) . 271
The use of TRESP genotyping in this study identified the isolates to be genetically different. 272
This approach was easy and accessible and only required the whole-genome sequence of the 273 isolates, in contrast to other traditional typing methods with much lower discriminatory 274 power (MLST) (32), laborious microsatellite determination (STRAf) (33), and the most novel 275 whole-genome SNP based typing method which is highly dependent on the quality of 276 sequencing, variant calling parameters and selection of a genetically close reference strain 277
(21). 278
We show evidence that supports the observation that all fungi have the ability to cause 279 disease and that members of the A. fumigatus species lack the sophisticated virulence factors, 280 commonly used to describe differences in virulence in species of the bacterial kingdom, that 281 could explain differences in their pathogenic traits (25, 34) . In order to define what makes a 282 virulent A. fumigatus isolate many researchers have attempted characterizing different 283 aspects of the fungus: differences in the colonial and spore color phenotype (25), the strain-284 dependent immunomodulatory properties induced in the host (25), the clinical or 285 environmental source of the isolate (13, 25, 26) , the strains ability to adapt and grow in 286 stressful conditions like low oxygen microenvironments where hypoxia fitness was strongly 287 correlated with an increase in virulence (26), and the ability of the fungus to adjust its gene 288 expression to survive in different immunosuppressive conditions inside the host (3). These 289 are all aspects that influence how fit a strain will be to produce an infection and further 290 research on the virulence of this microorganism should take all these aspects into 291 consideration when characterizing an experimental and/or clinical strain. The combined 292 results of these studies could be used to explore the link between the virulent phenotype and 293 genotype to better understand the mechanisms of infection of this important human 294
pathogen. 295
There are some limitations to be considered in this study. First, the number of isolates was 296 small, however three different A. fumigatus population sources (clinical, environmental and 297 experimental) were included. Nevertheless, we encourage our findings to be confirmed in a 298 larger population to fully confirm the observation that all members of this species are 299 potentially pathogenic. Second, we included 244 genes in our in-house database and we do 300 not rule out the possibility that other genes that have not yet been characterized/described 301 could also be considered as VRG. 302
In conclusion, we developed an in-house database with 244 VRG and found them all (except 303 Afu5g12720) in the whole-genome sequence of nine A. fumigatus isolates, five clinical, two 304 environmental and two experimental. This indicates, the strain-specific virulence genomic 305 profile cannot be explained by the source of isolation when looking at differences in virulence 306 related gene content or sequence variations. Understanding under what circumstances VRGs 307 are expressed and utilized may ultimately contribute to explain how they regulate their 308 virulence. Moreover, a broad genomic variability and the convenient location of transposable 309 elements that are acknowledged to be shaping the genome, evidences a very efficient capacity 310 of adaptation and challenges the development of specific diagnostic tools and effective 311
treatments. 312 313
Methods 314
A. fumigatus isolates and background. A. fumigatus samples evaluated in this study are 315 summarized in Table 1 . Four clinical isolates were included: three isolates (P1MS, P1MR and 316
P2CS) obtained at the University Medical Center Groningen (UMCG), Groningen, the 317
Netherlands, and the strain B5233, kindly provided by the Institute for Disease Control & 318
Prevention of the Academy of Military Medical Sciences, Beijing, China. B5233 is a clinical 319
isolate that demonstrated a high virulence in murine infection studies, and it has been used as 320 an experimental strain in A. fumigatus pathogenicity studies (35, 36) . The four isolates were 321 initially identified as A. fumigatus by microscopic morphological description and sequencing 322 of the internal transcribed spacer (ITS) region using Sanger sequencing. 323 P1MS and P1MR were originally isolated from the sputum of the same patient at different 324 time points during a complicated Influenza A H1N1 virus infection, and were regarded as 325 mixed infection isolates ( Figure 1 ). This patient had no relevant underlying disease, was 326 diagnosed with Influenza A H1N1 virus and was admitted to the UMCG. Two days after 327 admission, a positive sputum culture of A. fumigatus prompted the initiation of treatment with 328 voriconazole. Later, at day five after admission, the patient developed IA and passed away 329 sixteen days after the diagnosis of the fungal infection. Throughout the course of the IA 330 infection (21 days), a total of seven A. fumigatus isolates were recovered, where the first five 331
isolates were susceptible to azole treatment and the last two were resistant. We selected the 332 first susceptible and the first resistant isolates to determine their genetic relatedness. 333
The remaining isolate, P2CS, was recovered from an individual diagnosed with HIV and COPD. 334
The A. fumigatus was cultured during a COPD exacerbation event. Chronic pulmonary 335 aspergillosis was discarded after a chest imaging study without the radiological 336 characteristics of pulmonary aspergillosis. Since no indicative symptoms of aspergillosis were 337 identified, the patient was regarded as colonized by this strain. The patient is still under 338 treatment with antiviral therapy ODEFSEY (emtricitabine/tenofovir alafenamide/rilpitvirine) 339 and treatment for COPD with fluticason, cotrimoxazol, formeterol and ipratropium. 340
In addition, the raw sequencing data of five unrelated Dutch and English isolates with an 341 environmental or clinical origin (22), were downloaded from the European Nucleotide 342
Archive (ENA) and included in the study (Table 1) . 343
Antifungal susceptibility testing To determine the in vitro susceptibility of the clinical 344 isolates to triazole antifungal drugs the agar-based gradient technique for quantitative 345
antifungal susceptibility E-test (AB BIODISK, Solna, Sweden) was used for isolates B5233 and 346 P1MS, the agar-based method VIPcheck TM test (Nijmegen, The Netherlands) was used for 347 isolate P2CS and the susceptibility of P1MR was determined with the in vitro EUCAST broth 348 microdilution reference method (37). 349 denatured and diluted to the required (equi)molarity for Illumina platform and two pools 370 were made each containing two libraries. Whole-genome sequencing was performed in two 371 separate runs using the MiSeq Reagent Kit v2 500-cycles Paired-End on a MiSeq Sequencer 372 (Illumina). The raw reads generated in this study have been submitted to the European 373
DNA isolation
Nucleotide Archive under project accession number PRJEB28819. 374 Quality control and de-novo assembly. The raw sequencing reads were quality trimmed 375 using the CLC Genomics Workbench software version v10.1.1 using default settings except for 376 the following modifications: "trim using quality scores was set to 0.01". Assembly quality data 377 of the nine A. fumigatus isolates is shown in Table S1 . De-novo assembly produced acceptable 378 results that surpassed a >100 coverage with >90% of reads used. 379
Identification of virulence related genes. A database with genes associated with virulence 380
was generated based on Abad et al review (38). In addition, these genes were validated using 381 the online gene database AspGD (http://www.aspgd.org/). To increase the number of genes 382
and update the database, we added secondary metabolite (SM) genes from Biosynthetic Gene 383 Clusters (BGCs) 3, 5, 6, 14, 15 and 25, that showed a differential gene expression in murine 384 infection studies reported by Bignell et al (18) . A list of allergens recently revised was also 385 included (39). A database with a total of 244 genes was created with genes categorized into 386 seven big groups according to their site and the process they are involved in, as follows: 387 thermotolerance, resistance to immune responses, cell wall, toxins and secondary 388 metabolites, allergens, nutrient uptake and signaling and regulation. (Table S2) The de-novo 389 assemblies of our isolates were screened with ABRicate v0.3 software tool 390 (https://github.com/tseemann/abricate) to detect the presence or absence of VRGs included 391 in the database. The thresholds were set to >90% coverage and >90% identity to determine 392 the presence of a virulence gene. 393
TRESP genotyping. This method is based on hypervariable Tandem Repeats located within 394
Exons of Surface Protein coding genes (TRESP) encoding cell wall or plasma membrane 395 proteins (20). The allele sequence repeats of three TRESP targets is combined to assign a 396 specific genotype: an MP-2 antigenic galactomannan protein (MP2), a hypothetical protein 397 with a CFEM domain (CFEM) and a cell surface protein A (CSP). The allele repeats of these 398 previously described proteins were used to Create a Task Template by Allele Libraries in 399 SeqSphere+ software v5.1.0 (Ridom GmbH, Münster, Germany) with import option: use as 400 reference sequence "best matching allele", which enabled a dynamic reference sequence. The 401 assembled genomes were imported into SeqSphere+ and the specific target repetitive 402 sequences of each protein were analyzed for each UMCG isolate using the Seqsphere+ "find in 403
sequence" tool to identify the specific genotype. 404
Comparative genomics. Genome assemblies of novel isolates were aligned using blast+ v2.6 405 (40) and reads were mapped with bowtie2 v2.2.5 (41) to the eight reference chromosomal 406 genomes of Af293 (NC_007194 -NC_007201). For each contig, local alignment coordinates 407 were extended to their whole length using the highest bitscore with an in-house script. Mean 408 coverage were calculated every 5 Kb using bedtools v2.17 (42). VRGs location were 409 determined by local alignment and GC percentage were calculated every 100 bp with 410 https://github.com/DamienFr/GC-content-in-sliding-window-script. Coding sequences, their 411 location and frame where extracted from the reference sequence genbank files. All gathered 412 information was represented in a circular image using circos v0. 69-3 (43) . In addition, identification of SNPs present in VRGs of our isolates, was performed using CLC 432
Genomics Workbench software version v11.0.1. For this approach, trimmed reads of each 433 genome were mapped to a concatenated sequence consisted of 244 VRG genes described in 434 
